← FDA Drug Approvals (Drugs@FDA)

VARUBI

NDA · New Drug Application · Sponsor: TERSERA · Approved 2017-10-25

Drug application

FDA Application #

NDA208399

Application type

New Drug Application

Brand name

VARUBI

Generic name

Rolapitant Hydrochloride

Active ingredients

ROLAPITANT HYDROCHLORIDE

Dosage form

EMULSION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

TERSERA

First approval

2017-10-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown